Blockbuster Therapy Predictor#

Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.

Features#

• Multi-Source Data Integration: Aggregates clinical trials, patents, and funding data
• Predictive Scoring: Calculates Blockbuster Index combining maturity, market potential, and momentum
• Technology Landscape Mapping: Tracks 10+ emerging therapeutic platforms
• Investment Intelligence: Provides data-driven R&D and investment recommendations
• Trend Analysis: Identifies acceleration patterns and inflection points

Usage#

Basic Usage#

bash

# Run complete analysis with all technologies
python scripts/main.py

# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR

# Output in JSON format
python scripts/main.py --output json

Parameters#

ParameterTypeDefaultRequiredDescription--modestrfullNoAnalysis mode: full or quick--techstrNoneNoComma-separated list of technologies to analyze--outputstrconsoleNoOutput format: console or json--thresholdfloat0NoMinimum blockbuster index threshold (0-100)--savestrNoneNoSave report to file path

Advanced Usage#

bash

# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
  --threshold 70 \
  --output json \
  --save high_potential_report.json

# Quick analysis of specific platforms
python scripts/main.py \
  --mode quick \
  --tech CAR-T,ADC,Bispecific \
  --output console

Output#

Console Output#

text

🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10

📊 Technology Rankings
Rank  Technology       Blockbuster Index    Maturity    Market Potential    Momentum    Recommendation
🥇 1   mRNA             85.2                 78.5        92.1                88.0        Strongly Recommended
🥈 2   CAR-T            82.3                 85.2        78.5                75.0        Strongly Recommended
🥉 3   CRISPR           79.8                 72.3        88.2                68.0        Recommended

JSON Output Structure#

json

{
  "generated_at": "2026-02-15T10:30:00",
  "total_routes": 10,
  "rankings": [
    {
      "rank": 1,
      "tech_name": "mRNA",
      "blockbuster_index": 85.2,
      "maturity_score": 78.5,
      "market_potential_score": 92.1,
      "momentum_score": 88.0,
      "recommendation": "Strongly Recommended",
      "key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
      "risk_factors": ["Regulatory uncertainties"],
      "timeline_prediction": "First product expected in 2-4 years"
    }
  ]
}

Scoring Methodology#

Blockbuster Index Formula#

text

Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)

Component Scores#

ComponentWeightFactorsMarket Potential50%Market size, unmet need, competitionMaturity30%Clinical stage, patent depth, funding stageMomentum20%Patent growth, funding activity, clinical progress

Investment Recommendation Thresholds#

Blockbuster IndexRecommendationAction≥ 80Strongly RecommendedPrioritize R&D investment60-79RecommendedActive monitoring and early partnerships40-59WatchMonitor milestones; reassess in 6-12 months< 40CautiousMinimal investment; consider divestment

Supported Technologies#

TechnologyCategoryDescriptionPROTACProtein DegradationProteolysis Targeting ChimeramRNANucleic Acid DrugsMessenger RNA therapy platformCRISPRGene EditingCRISPR-Cas gene editing technologyCAR-TCell TherapyChimeric Antigen Receptor T-cell therapyBispecificAntibody DrugsBispecific antibody technologyADCAntibody DrugsAntibody-Drug ConjugateRNAiNucleic Acid DrugsRNA interference therapyGene TherapyGene TherapyAAV vector gene therapyAllogeneicCell TherapyUniversal/Allogeneic cell therapyCell TherapyCell TherapyGeneral cell therapy platform

Technical Difficulty: MEDIUM#

⚠️ AI自主验收状态: 需人工检查

This skill requires:

• Python 3.8+ environment
• Basic understanding of biotech investment analysis
• Access to clinical trial, patent, and funding databases (optional)

Dependencies#

Required Python Packages#

bash

pip install -r requirements.txt

Requirements File#

text

dataclasses
enum

Risk Assessment#

Risk IndicatorAssessmentLevelCode ExecutionPython scripts executed locallyMediumNetwork AccessNo external API calls in mock modeLowFile System AccessRead/write report files onlyLowInstruction TamperingStandard prompt guidelinesLowData ExposureOutput files saved to workspaceLow

Security Checklist#

• No hardcoded credentials or API keys
• No unauthorized file system access (../)
• Output does not expose sensitive information
• Prompt injection protections in place
• Input file paths validated (no ../ traversal)
• Output directory restricted to workspace
• Script execution in sandboxed environment
• Error messages sanitized (no stack traces exposed)
• Dependencies audited

Prerequisites#

bash

# Python dependencies
pip install -r requirements.txt

Evaluation Criteria#

Success Metrics#

• Successfully executes main functionality
• Output meets quality standards
• Handles edge cases gracefully
• Performance is acceptable

Test Cases#

1. Basic Functionality: Run without arguments → Expected output with all technologies
2. Technology Filter: Use --tech flag → Only specified technologies analyzed
3. JSON Output: Use --output json → Valid JSON format output
4. Threshold Filter: Use --threshold 70 → Only technologies with index ≥70 shown

Lifecycle Status#

• Current Stage: Draft

• Next Review Date: 2026-03-15

• Known Issues: None

• Planned Improvements:

  • Integration with real-time data APIs
  • Additional technology platforms
  • Enhanced visualization capabilities

References#

See references/ for:

• Historical blockbuster case studies
• Clinical trial data sources
• Patent analysis methodologies
• Investment scoring frameworks

Limitations#

• Data Source: Uses mock data for demonstration; real-time data integration required for production use
• Prediction Accuracy: Model provides indicative scores; not investment advice
• Technology Coverage: Limited to pre-configured technology platforms
• Market Dynamics: Cannot predict black swan events or regulatory changes
• Regional Bias: Data primarily focused on US/EU markets

---

⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.